MedicaidBilling CodesMedium impact
22-067 Stay Current with the Injectable Medication HCPCS/DOFR Crosswalk Reference Table - 1st Quarter 2022
Health Net·CA · Oncology, Family Medicine, Internal Medicine +2 more·Pharmacy
Effective date
Apr 18, 2022
We identified it
Jun 20, 2026
Summary
Health Net updated their Injectable Medication HCPCS/DOFR Crosswalk for Medi-Cal providers in specific California counties, adding 11 new injectable medications and updating 16 existing medication codes. Several medications are no longer manufactured and their codes should be discontinued.
Action Required
By April 18, 2022: Billing team must update billing system with 11 new injectable medication HCPCS codes and their corresponding DOFR categories. Replace 16 existing codes with updated versions (e.g., replace J3590 with Q2055 for Abecma, J2505 with J2506 for Neulasta). Discontinue billing for 6 medications no longer manufactured including Omontys, Protropin, and Vitrasert. Update encounter forms and medication lists to reflect these changes.